Does Immunotherapy Offer Survival Gain in Older NSCLC Patients? ...Middle East

Medscape - News
Contrary to clinical trial results, the survival benefit of checkpoint inhibitors in the real-world setting is lower among older people with NSCLC, who make up a large proportion of patients. Medscape Medical News

Hence then, the article about does immunotherapy offer survival gain in older nsclc patients was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Does Immunotherapy Offer Survival Gain in Older NSCLC Patients? )

Apple Storegoogle play

Last updated :

Also on site :